Health Research Policy and Systems
10:18, 2012.

Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators.
Rahim Rezaie, Anita M. McGahan, Sarah E. Frew, Abdallah S. Daar and Peter A. Singer.
http://www.health-policy-systems.com/content/10/1/18

This paper analyzes factors that influence innovative activity in the indigenous health biotechnology and pharmaceutical sectors of China, India, Brazil, and South Africa. It a) shows how biopharmaceutical innovation is taking place within the entrepreneurial sectors of these emerging markets, b) identifies common challenges that indigenous entrepreneurs face, c) highlights the key role played by the state in advancing innovation, and d) reveals that the transition to innovation by companies in the emerging markets is characterized by increased global integration.